By Editor

I’ve always been fascinated by space… I grew up on Dune, 2001: A Space Odyssey, and (pre-Disney) Star Wars. The prospect of humanity exploring the stars, deploying satellites, and potentially…

Search Stock Profiles

Latest News

The Biotech Bonanza: A Wild Ride Through the Stock Market Jungle

Buckle up, folks, because the biotech stock market as of March 26, 2025, is a jungle…

By Editor

GOOGL: Alphabet Stock – Buy or Sell This Search Superstar?

Alphabet (GOOGL/GOOG) is the brainy nerd running the internet, lounging at $167.68 (MacroTrends) as of March…

By Editor

VRTX: Vertex Pharmaceuticals – Buy or Sell This Biotech Beast?

Vertex Pharmaceuticals (VRTX) is the biotech jungle’s roaring lion, lounging at $485.58 (StockAnalysis.com) with a market…

By Editor

NVDA: Nvidia Stock – Time to Buy or Sell This AI Rockstar?

Nvidia (NVDA) is the electrifying frontman of the tech scene, rocking the AI and semiconductor stage…

By Editor

How Retail Investors Outplayed Wall Street in April

Retail investors crushed it in April 2025 — buying when hedge funds bailed and turning the…

By Editor

The Auction Heard ‘Round Wall Street

Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt the ground shift beneath…

By Editor

BNTX: BioNTech – Buy or Sell This Biotech Trailblazer?

BioNTech (BNTX) is the biotech jungle’s speedy cheetah, sprinting at $95.50 (TipRanks) with a $35 billion market cap as of…

By Editor
2 Min Read

AMGN: Amgen – Buy or Sell This Biotech Bruiser?

Amgen (AMGN) is the biotech jungle’s hulking gorilla, stomping at $283.50 (TipRanks) with a $100 billion+ market cap as of…

By Editor
2 Min Read

ABNB: Airbnb Stock – Buy or Sell This Travel Trailblazer?

Airbnb (ABNB) is the travel renegade crashing couches at $128.80 (StockAnalysis.com) as of March 26, 2025. It’s the cool kid…

By Editor
2 Min Read